Table 4 Outcomes in the intervention trial
Outcomes | Early RRT (n = 58) | Standard RRT (n = 60) | p value |
|---|---|---|---|
Primary outcome | |||
 Mortality, n (%) | 36 (62.1) | 35 (58.3) | 0.68 |
Secondary outcomes | |||
 Recovery, n (%) | 21 (36.2) | 19 (31.7) | 0.60 |
 7-day fluid balance (mL), median (IQR) | −1702 (−5610 to 2129) | −1247 (−4535 to 1581) | 0.75 |
 Mean RRT dose (mL/kg/h), mean (SD) | 26.8 (5.3) | 26.3 (8.9) | 0.73 |
 RRT-free days, median (IQR) | 0 (0–19) | 0 (0–28) | 0.64 |
 MV-free days, median (IQR) | 4 (0–24) | 0.5 (0–20.3) | 0.66 |
 ICU-free days, median (IQR) | 14 (0–21) | 4.5 (0–18) | 0.46 |
 ICU length of stay (days), median (IQR) | 12 (7–26) | 13.5 (9–29) | 0.76 |
 Hospital length of stay (days), median (IQR) | 26 (19–53) | 28.5 (17–55.3) | 0.82 |
 Renal replacement therapy dependency at day 28, n (%) | 7 (12.1) | 10 (16.7) | 0.77 |